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The endocytosis of E-cadherin has recently emerged
as an important determinant of cadherin function with
the potential to participate in remodeling adhesive con-
tacts. In this study we focused on the initial fate of
E-cadherin when it predominantly exists free on the cell
surface prior to adhesive binding or incorporation into
junctions. Surface-labeling techniques were used to de-
fine the endocytic itinerary of E-cadherin in MCF-7 cells
and in Chinese hamster ovary cells stably expressing
human E-cadherin. We found that in this experimental
system E-cadherin entered a transferrin-negative com-
partment before transport to the early endosomal com-
partment, where it merged with classical clathrin-medi-
ated uptake pathways. E-cadherin endocytosis was
inhibited by mutant dynamin, but not by an Eps15 mu-
tant that effectively blocked transferrin internalization.
Furthermore, sustained signaling by the ARF6 GTPase
appeared to trap endocytosed E-cadherin in large pe-
ripheral structures. We conclude that in isolated cells
unbound E-cadherin on the cell surface is predomi-
nantly endocytosed by a clathrin-independent pathway
resembling macropinocytotic internalization, which
then fuses with the early endosomal system. Taken with
earlier reports, this suggests the possibility that multi-
ple pathways exist for E-cadherin entry into cells that
are likely to reflect cell context and regulation.
Cadherin cell adhesion molecules support cell-cell adhesion
and recognition in most tissues of the body (1–3). E-cadherin is
the predominant cadherin found in epithelia, where it localizes
to specialized adherens junctions between cells, as well as
being found more generally in the lateral plasma membrane
where cells come into contact with one another. Like other
classical cadherins, E-cadherin is a key determinant of tissue
organization both during development and in post-embryonic
life (2). Of note, E-cadherin contributes to morphogenetic
patterning in the early embryo and during organogenesis,
where it participates in dynamic adhesive contacts that may
be different from those found in classical adherens junctions
(4–7). Conversely, loss of E-cadherin function is an important
step in epithelial tumor progression to invasiveness and
metastasis (8).
In many instances, the morphogenetic influence of E-cad-
herin and other classical cadherins is critically influenced by
changes in the cell surface expression of these molecules. For
example, quantitative as well as qualitative changes in cad-
herin expression determine cell sorting both in cell culture
models (9) as well as in the early embryo (10). Indeed, both
quantitative and qualitative changes in cadherin expression
are subject to developmental regulation (5, 6). Down-regulation
of E-cadherin, by either transcriptional silencing or protein
degradation, also occurs during epithelial-mesenchymal tran-
sitions during organogenesis and tumorigenesis (11). However,
many very dynamic morphogenetic events entail regulated
changes in cadherin activity that are not attributable to alter-
ations in either the overall level of protein expression, or to
changes in the repertoire of cadherins expressed at the cell
surface. This is exemplified by cell-upon-cell locomotion in the
Drosophila ovary (7) and in Xenopus embryos (12), where cad-
herin adhesions provide the traction for cells to move upon one
another, but must also be regulated and remodeled to allow
translocation to occur.
Post-Golgi trafficking of E-cadherin has recently emerged as
an alternative mechanism to support dynamic changes in cad-
herin activity. We found that polarized Madin-Darby canine
kidney epithelial cell monolayers display some internalization
of cell surface E-cadherin (13). This entered an early endosomal
compartment and was then recycled back to the cell surface
relatively quickly (time scale of 15–30 min) without undergoing
degradation. Importantly, this post-Golgi trafficking pathway
contributed to the remodeling of cell-cell contacts: blocking the
recycling of internalized E-cadherin back to the cell surface
significantly perturbed the ability of cells to re-establish cad-
herin-based cell-cell contacts that had been disrupted by ma-
nipulation of extracellular calcium. We postulated that recy-
cling of E-cadherin might provide a mechanism for cadherin-
based contacts to be rapidly remodeled during morphogenesis
and tissue reorganization. Indeed, inhibition of dynamin activ-
ity blocked morphogenesis in the early Xenopus embryo, closely
correlated with disturbances in C-cadherin trafficking (14).
In addition to being constitutively active in polarized mono-
layers, E-cadherin internalization and trafficking is also sub-
ject to cellular regulation. Growth factors that induce epithelial
cell scattering appear to promote E-cadherin internalization
(15–17). A variety of intracellular signaling pathways, which
include the Rac (18) and ARF6 GTPases (17) and protein ki-
nase C (19) can also influence cadherin trafficking. In the case
of protein kinase C, this affects both internalization of E-cad-
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herin from the membrane as well as its recycling back to the
cell surface (19). Finally, E-cadherin recycling may be regu-
lated by the activity state of the cadherin itself: cell-cell contact
appeared to withdraw cadherin from the recycling pathway,
whereas disruption of cell-cell contacts promoted the internal-
ization of E-cadherin (13).
Taken together, these data indicate that the initial step of
cadherin endocytosis is likely to be a key point in cadherin
trafficking. This would be consistent with evidence that the
endocytosis of a wide range of cell surface molecules is subject
to stringent cellular control (20, 21). The precise mechanism for
E-cadherin endocytosis is, however, incompletely understood.
A wide repertoire of mechanisms exist for cell surface mole-
cules to be internalized, including both classic clathrin-medi-
ated endocytosis (22) and a variety of clathrin-independent
pathways (21). Interestingly, recent studies have presented
evidence that E-cadherin might be internalized by either clath-
rin-dependent (13, 23) or clathrin-independent mechanisms
(18), suggesting that multiple pathways may also exist for
E-cadherin internalization. Many of these studies were con-
ducted in fully confluent cultured cell monolayers, which more
closely resemble the situation in mature epithelia with stable
adhesive contacts, rather than the dynamic adhesive contacts
formed during tissue reorganization. In the latter case, turn-
over of adhesion is likely to be rapid, requiring mechanisms for
unbound cadherin molecules to be cleared away from regions of
the cell surface undergoing remodeling (24). In this study we
therefore chose to focus on characterizing the initial fate of
unbound E-cadherin on the cell surface of isolated MCF-7 and
CHO1 cells. Combining surface labeling assays with light and
immunoelectron microscopy our experiments identify a clath-
rin-independent pathway for E-cadherin internalization that is
subject to regulation by ARF6.
MATERIALS AND METHODS
Cell Culture—MCF-7 cells were grown in Dulbecco’s modified Eagle’s
medium (BioWhittaker), CHO cells in Hams’ F-12 (BioWhittaker), and
all media were supplemented with 10% (v/v) fetal bovine serum, peni-
cillin, streptomycin, and non-essential amino acids (Invitrogen). CHO
cells stably expressing human E-cadherin were used as described pre-
viously (25, 26). Cells were incubated at 37 °C, with 5% CO2 in 95% air.
Cells used for immunofluorescence were plated on glass coverslips. All
transient transfections were carried out with LipofectAMINE Plus (In-
vitrogen) according to the manufacturer’s instructions. Transfected
cells were grown for 16–24 h before being used in experiments.
Antibodies—Primary antibodies used were: 1) mouse monoclonal
antibody HECD-1 raised against the ectodomain of human E-cadherin
(a kind gift from Prof. Masatoshi Takeichi; Kyoto University), 2) human
anti-early endosomal antigen-1 (EEA-1; a gift from Dr. Ban Hock Toh,
Monash University), 3) rabbit anti-Rab-7 and 4) rabbit anti-HA (both
provided by Prof. David James, University of Queensland), 5) rabbit
anti-cathepsin D (UBI), 6) rabbit anti-GFP (Molecular Probes), and 7)
rabbit anti--COP (a kind gift from Dr. Rohan Teasdale, University of
Queensland). Secondary antibodies used were: 1) Alexa-488 conjugated
goat anti-rabbit IgG (Molecular Probes), 2) Cy3-conjugated donkey anti-
mouse IgG (Jackson Immunoresearch Laboratories), 3) Cy3-conjugated
goat anti-mouse IgG F(ab)2 fragment-specific antibodies (Jackson
Labs). F(ab) fragments of hECD-1 were generated using the Immuno-
pure IgG1 F(ab) and F(ab)2 preparation kit (Pierce).
Internalization Assay—MCF-7 cultures were passaged 12 h before
experiments, and on the day of the assay the cell medium was changed
to Hanks’ balanced salt solution supplemented with 5 mM Ca2 and 50
mg/ml bovine serum albumin and cells were allowed to equilibrate for
1 h. Samples were then incubated for 1 h at 4 °C with HECD-1 F(ab)
fragments or intact HECD-1 IgG diluted in Hanks’ balanced salt solu-
tion. Coverslips were washed with ice-cold PBS to remove the unbound
antibody and the media was replaced with Hanks’ balanced salt solu-
tion prewarmed to 37 °C. After incubation at 37 °C for varying periods
of time, cells were then washed with PBS and returned to 4 °C. The
residual surface-bound antibody was removed by acid washing (0.5 M
acetic acid, 0.5 M NaCl; 3 5 min washes) (27). Cells were washed with
PBS before fixation with 4% paraformaldehyde (in 10 mM PIPES, 2 mM
MgCl, 2 mM KCl, 300 mM sucrose, and 2 mM EGTA) for 20 min at 4 °C.
Plasmids—The following plasmids were transiently transfected into
either MCF-7 or CHO cells: pCB/Dynamin-1 S45N (a kind gift from Dr.
Sandy Schmid (28), pEYFP-Cav3 (29), pEGFP-Eps-15/E95/295 (kindly
provided by Drs. Ben Nichols and Alexandre Benmerah (30, 31)), pXS/
Arf-6, pXS/Arf-6 T27N, and pXS/Arf-6 (generous gifts from Dr. Julie
Donaldson), pEGFP/Rab5 Q79L (32), and pEGFP/Rab 11 (33).
Immunofluorescence Microscopy—Unless otherwise stated, cells
were fixed with 4% paraformaldehyde for 20 min, washed with PBS,
then permeabilized in 0.25% Triton X-100/PBS. After fixation and per-
meabilization, samples were washed in PBS, then incubated in blocking
buffer (5% (w/v) nonfat dried milk in PBS) for 1 h. Primary and second-
ary antibodies were diluted in blocking buffer and incubated serially for
60 min at room temperature. After final washing with PBS, samples
were mounted in 1% NPG, 50% glycerol/PBS. Images were acquired
with an Olympus AX70 microscope and Orca I digital camera
(Hamamatsu) using Metamorph Imaging Software (version 4.01, Uni-
versal Imaging Corp.). Images were compiled using Adobe Photoshop 6.
Electron Microscopy—To characterize the surface distribution of E-
cadherin, isolated MCF-7 cells were fixed with 0.5% glutaraldehyde,
then incubated with HECD-1 IgG for 1 h, before sectioning and proc-
essing for electron microscopy as previously described (34). Surface-
labeled HECD-1 was detected using 5 nm anti-mouse gold. To quanti-
tate the distribution of surface label, 400 gold particles were counted
from sections of 15 independent cells.
RESULTS
Itinerary of Surface-labeled E-cadherin Internalization—E-
cadherin internalization was assayed with a surface labeling
strategy that has been extensively used to characterize endo-
cytosis of the transferrin receptor and many other cell surface
proteins (35, 36). For these experiments we used MCF-7 cells,
a well differentiated human breast cancer cell line that ex-
presses endogenous E-cadherin. To maximize the rate of inter-
nalization, cells were passaged 12 h prior to experiments to
obtain sparse, subconfluent cultures. This provided an optically
amenable system where cell surface proteins were readily ac-
cessible for labeling. To label the surface pool of E-cadherin,
cells were incubated at 4 °C with F(ab) fragments or whole IgG
of monoclonal antibody HECD-1 directed against the ectodo-
main of human E-cadherin. After washing to remove unbound
antibody, samples were then warmed to 37 °C to allow inter-
nalization of surface-labeled E-cadherin to resume. At various
times after release of the 4 °C block any residual antibody on
the cell surface was stripped by washing with a high-salt/acid
buffer (27) and the samples were processed to detect the inter-
nalized label by indirect immunofluorescence microscopy.
As shown in Fig. 1A, immediately after labeling at 4 °C,
HECD-1 F(ab) staining was found distributed throughout the
free surface of cells as well as being concentrated in areas of
cell-cell contact. High salt/acid washing immediately after la-
beling removed almost all staining (Fig. 1B), confirming effi-
cient stripping of the surface-bound label. Within 5 min after
warming cells to 37 °C, HECD-1 F(ab) could be detected in
peripheral cytoplasmic vesicles that were resistant to surface
stripping (Fig. 1C). Vesicular staining of internalized HECD-1
F(ab) increased progressively after release of the 4 °C block,
becoming extensively distributed throughout the cytoplasm
and in the perinuclear region after 30 min (Fig. 1, D–F).
Comparison of E-cadherin Internalization with Clathrin-me-
diated Endocytosis—To begin to characterize the E-cadherin
internalization pathway, we compared the localization of sur-
face-labeled E-cadherin with that of transferrin, a well charac-
terized marker of clathrin-mediated endocytosis (20, 36). Cells
were surface-labeled with both HECD-1 and fluorescein-conju-
gated transferrin and their itineraries of internalization com-
pared at various times after release of the 4 °C block. For these
1 The abbreviations used are: CHO, Chinese hamster ovary; EEA-1,
early endosomal antigen-1; PBS, phosphate-buffered saline; PIPES,
1,4-piperazinediethanesulfonic acid.
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studies we used both whole HECD-1 IgG (Fig. 2, A–D) and
HECD-1 F(ab) fragments (Fig. 2, E and F) with identical
results. After 15–30 min internalization (Fig. 2, B–D and F)
HECD-1 co-localized extensively in vesicles that were also pos-
itive for transferrin, suggesting that at this time internalized
E-cadherin and transferrin resided in the same compartment.
However, a striking disparity was detected between E-cadherin
and transferrin at earlier stages of internalization. After 5 min
internalization (Fig. 2, A and E), although E-cadherin and
transferrin were readily detected in distinct vesicles, these did
not co-localize. This suggested that although the trafficking
pathways for these two proteins merged at some stage, their
initial entry pathways might be different.
To pursue this we compared staining for endogenous clathrin
with that of surface-labeled E-cadherin after 15 min internal-
ization. Clathrin stained in two major patterns: a perinuclear
distribution consistent with Golgi-associated clathrin and more
diffuse peripheral puncta that likely represent both clathrin-
coated pits and coated vesicles (Fig. 2G). Little internalized
E-cadherin co-localized with clathrin (Fig. 2G). This was most
apparent at the cell periphery where E-cadherin and clathrin
were clearly identified in quite separate structures (Fig. 2H).
Internalized E-cadherin Enters the Early Endosomal Com-
partment—We then sought to characterize the relationship
between internalized E-cadherin and the endosomal compart-
ment. After 15–30 min internalization we found that many
vesicles containing internalized HECD1-F(ab) also stained for
the early endosomal marker, EEA-1 (Fig. 3B). However, at 5
min we could detect no co-localization between EEA-1 and
HECD1-F(ab), which labeled quite distinct vesicles (Fig. 3A).
In contrast, as has generally been reported (33, 37), after 5 min
many transferrin-positive vesicles were identified that also
stained for EEA-1 (Fig. 3, C and D). This suggested that E-
cadherin was internalized via an EEA-1-negative intermediary
compartment before entering the early endosomal system.
To confirm that E-cadherin was trafficked into an early
endosomal compartment, we examined the pattern of cadherin
uptake in cells transiently expressing a Rab5 mutant (Q79L)
that causes fusion of early endosomes (33, 37). As shown in Fig.
3E, endocytosed E-cadherin accumulated in enlarged vesicles
that coincided precisely with the localization of the Rab5 mu-
tant transgene. This is consistent with previous reports that
expression of this mutant causes cargo to accumulate in en-
larged early endosomes (37). To assess whether E-cadherin
could also enter the recycling endosomal compartment, we
compared the localization of internalized E-cadherin with that
of Rab11, a key marker of recycling endosomes (36). After 30
min internalization, we found that a proportion of surface-
labeled E-cadherin was found in vesicles that also stained for
transiently transfected Rab 11-GFP (Fig. 3F).
Taken together, these data indicated that internalized E-
cadherin was trafficked to the early endosomal system, where
at least a proportion was able to access recycling endosomes. In
contrast, internalized E-cadherin was not found in Rab 7-pos-
itive vesicles (Fig. 4A), part of the late endosomal system. Nor
was any co-localization seen in cells stained for cathepsin D
(Fig. 4B), a protease found in lysosomes, or for -COP, a
marker of the Golgi apparatus (Fig. 4C).
E-Cadherin Is Not Internalized by Caveolae in Isolated CHO
Cells—It was recently suggested that E-cadherin may be inter-
nalized through a caveolar trafficking pathway, based on the
striking observation that sustained Rac signaling in keratino-
cytes caused E-cadherin to accumulate in large caveolin-posi-
tive cytoplasmic vacuoles (18). To investigate this possibility in
our system, we compared the localization of internalized E-
cadherin and caveolin, an essential component of caveolae.
Because MCF-7 cells have low levels of endogenous caveolin we
used a CHO cell line that stably expresses human E-cadherin
(hE-CHO cells) and which forms caveolae. hECHO cells were
transiently transfected with caveolin-3 YFP (Cav3-YFP), a con-
struct that is a faithful marker of caveolae at the light micro-
scopic level (29). hE-CHO cells effectively endocytosed surface-
bound HECD-1 (both whole IgG and F(ab) fragments),
displaying a pattern of vesicular staining qualitatively similar
to that seen in MCF-7 cells (Fig. 4D). Although Cav3-YFP was
clearly detected in punctate structures consistent with caveo-
lae, no co-localization with E-cadherin was seen at any stage
during our endocytosis assays (Fig. 4D). It thus seemed un-
likely that caveolae were principally responsible for E-cadherin
internalization in our model system.
Characterization of E-cadherin Internalization by Immuno-
electron Microscopy—To further examine the initial step by
which E-cadherin is internalized we employed electron micros-
copy in an attempt to identify distinct surface structures asso-
ciated with E-cadherin (Fig. 5). Cells were fixed with glutaral-
dehyde, and the cell surface was then labeled with monoclonal
antibody HECD-1 followed by 5 nm anti-mouse gold: under
these conditions, only surface E-cadherin is accessible for im-
munolabeling. Labeling was found throughout the entire cell
surface. Although most labeling was found on the undefined
plasma membrane (83.8  5.3%, mean  S.E., n  406 gold
particles counted), a significant proportion of gold particles
FIG. 1. Internalization of surface-la-
beled E-cadherin. Subconfluent MCF-7
cells were incubated with anti-E-cadherin
(HECD-1) F(ab) fragments at 4 °C, then
allowed to internalize the surface label at
37 °C for 0–60 min (B–F). Samples were
processed to identify the label by indirect
immunofluorescence microscopy immedi-
ately after labeling (A; NW, not washed),
or after washing with a high salt/acid so-
lution to strip residual surface F(ab)
(B–F). Bar is 15 m.
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were found in prominent invaginations of the plasma mem-
brane (15.3  5.1%), possibly indicative of ruffling activity or
macropinocytosis (Fig. 5, A and B). Labeling for E-cadherin in
clathrin-coated pits, in contrast, was extremely rare (1.0 
0.4% of surface gold; Fig. 5, C and D). Similar results were
obtained after surface labeling cells for E-cadherin with both
anti-cadherin and anti-mouse gold prior to allowing internal-
ization of the E-cadherin complex for various times at 37 °C
(results not shown). These observations indicated that E-cad-
herin did not show detectable concentrations in clathrin-coated
pits relative to the general plasma membrane.
Molecular Determinants of E-cadherin Endocytosis—To
characterize the molecular regulation of E-cadherin internal-
ization in isolated cells we first examined the potential role of
dynamin, a GTPase implicated in various forms of endocytosis
(22, 28). MCF-7 cells were transiently transfected with a well
characterized dominantly interfering mutant (S45N) of dy-
namin. Consistent with its established role in clathrin-medi-
ated endocytosis (22, 28), expression of dynaminS45N effectively
inhibited transferrin uptake in MCF-7 cells (Fig. 6, C and D).
In these studies we quantitated uptake of surface label by
scoring the number of cells that displayed a characteristic
pattern of widely distributed, vesicular uptake throughout the
cytoplasm. The vast majority of cells expressing dynaminS45N
showed no vesicular staining of internalized transferrin what-
soever (Fig. 6E). Expression of dynaminS45N also reduced the
proportion of cells displaying the characteristic diffuse vesicu-
lar pattern of E-cadherin uptake (from 80.9  3.4%, mean 
S.E., in controls to 35.0 7.4% in transfected cells; Fig. 6, A, B,
and E), although to a lesser extent than transferrin (from
90.7  1.7% in controls to 4.7  0.8% in transfected cells). This
indicated that dynamin activity contributed to E-cadherin in-
ternalization, although less critically than was associated with
transferrin uptake.
To specifically test whether E-cadherin might be internal-
ized by a clathrin-dependent pathway, we then perturbed the
function of EPS-15, a crucial component of clathrin-mediated
endocytosis (22). In agreement with previous studies (30, 31),
transient expression of the EPS-15E95/295 mutant reduced
the uptake of transferrin by 70% compared with control cells
(Fig. 7, A, B, and E). In contrast, EPS-15E95/295 had no
detectable effect on E-cadherin endocytosis (Fig. 7, C–E). After
30 min internalization, cells expressing EPS-15E95/295 dis-
played a distinct vesicular pattern of endocytosed E-cadherin
FIG. 2. Comparison of E-cadherin and clathrin-mediated up-
take pathways. A–F, comparison of E-cadherin internalization with
transferrin endocytosis. Isolated MCF-7 cells were incubated with ei-
ther HECD-1 IgG (A–D; E-Cad IgG, red) or HECD-1 F(ab) (E and F;
E-Cad F(ab), red) and fluorescently labeled transferrin (Tfn, green) at
4 °C, then allowed to internalize for 5–60 min, before residual label was
stripped and the samples processed for indirect immunofluorescence
microscopy. Bars are 3 (A–D) and 5 m (E and F). G and H, comparison
of internalized E-cadherin with endogenous clathrin immunostaining.
MCF-7 cells were labeled with HECD-1 F(ab) (red) that was allowed to
internalize for 15 min before fixation and staining for endogenous
clathrin (green) by dual-label indirect immunofluorescence microscopy.
The peripheral region highlighted in G is displayed in H. Bar is
8 m (G).
FIG. 3. Internalized E-cadherin enters the early endosomal
system. Isolated MCF-7 cells were surface-labeled with HECD-1 F(ab)
fragments (A, B, E, and F) or with fluorescently labeled transferrin (C
and D), then allowed to internalize the label for 5–15 (A–D) or 30 min
(E and F). After internalization, residual surface label was stripped and
the samples processed for fluorescence microscopy. Internalized E-cad-
herin (A, B, E, and F; red) or transferrin (C and D; red) was compared
with endogenous EEA-1 (A–D; green), transiently expressed Rab 5
(Q79L) (E; green) or transiently expressed GFP-Rab 11 (F; green). Bars
are 4 (A–D) and 10 m (E and F).
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(Fig. 7D), identical to that seen in control cells (not shown).
This strongly suggested that E-cadherin might be internalized
by a clathrin-independent pathway in isolated MCF-7 cells.
E-Cadherin Endocytosis Is Sensitive to the ARF6 GTPase—
The ARF6 GTPase defines a clathrin-independent pathway for
endocytosis and trafficking of a variety of membrane proteins
(38, 39). Recently, ARF6 signaling was reported to influence
the surface localization of E-cadherin in Madin-Darby canine
kidney cell monolayers (17, 23). Accordingly, we tested the
effect of manipulating ARF6 signaling on E-cadherin endocy-
tosis in our assay system. MCF-7 cells were transiently trans-
fected with ARF6Q67L, a mutant that is defective in GTPase
activity and predicted to be locked in the active GTP-bound
state (40). Consistent with previous reports (40), we found that
expression of ARF6Q67L did not affect transferrin uptake in
isolated MCF-7 cells (Fig. 8F). However, it potently perturbed
the pattern of E-cadherin internalization. Cells expressing
wild-type ARF6 (Fig. 8A) showed a characteristic pattern of
diffusely distributed E-cadherin vesicles after 30 min internal-
ization that was identical to that seen in untransfected cells
(not shown). In contrast to these controls, little vesicular stain-
ing of E-cadherin was detected in cells expressing ARF6Q67L
(Fig. 8, C and D). Internalization was not totally abrogated,
however, although the vast majority of cells failed to show
diffuse vesicular internalization, E-cadherin labeling was com-
monly detected in large peripheral structures that were resist-
ant to acid/salt stripping (Fig. 8D). In contrast, expression of an
ARF6T27N mutant had no apparent effect on E-cadherin inter-
nalization (Fig. 8B).
The accumulation of internalized E-cadherin in large periph-
eral structures, but not in diffuse vesicles, suggested that
ARF6Q67L might act on an early step during E-cadherin endo-
cytosis. To further characterize these peripheral structures we
co-labeled cells for E-cadherin and either transferrin or EEA1.
We found that in cells expressing ARF6Q67L the cadherin-
containing peripheral structures were largely devoid of either
endogenous EEA-1 (Fig. 8E) or internalized fluorescently la-
beled transferrin (Fig. 8F), a pattern analogous to that seen in
the early phases of E-cadherin internalization in untransfected
cells (Figs. 2 and 3), suggesting that ARF6Q67L might be trap-
ping this early compartment.
DISCUSSION
In this study we sought to characterize the process by which
unbound surface E-cadherin is internalized in isolated MCF-7
and CHO cells, an assay system chosen to allow us to focus on
the fate of E-cadherin that is not incorporated into stable
adhesive contacts (13). Several lines of evidence suggest that in
our experimental system the initial internalization of E-cad-
herin during endocytosis principally occurred via a clathrin-
independent mechanism. 1) At the earliest phase of internal-
ization, surface-labeled E-cadherin did not co-localize with
endocytosed transferrin, a classic marker of clathrin-depend-
ent endocytosis (32, 35). 2) Expression of a dominant-inhibitory
EPS 15 mutant had no effect on E-cadherin internalization,
despite effective inhibition of transferrin uptake to a degree
comparable with that previously reported (30, 31). 3) At the
light microscopic level internalized E-cadherin did not co-local-
ize significantly with endogenous clathrin; nor did E-cadherin
concentrate in clathrin-coated pits by immuno-EM. Taken to-
gether, these features of cadherin internalization resemble the
patterns seen with a range of other membrane proteins be-
lieved to be internalized by clathrin-independent endocytosis
FIG. 4. Comparison of E-cadherin internalization with alter-
nate trafficking pathways. MCF-7 cells (A–C) or CHO cells stably
expressing E-cadherin (D) were allowed to internalize surface-bound
HECD-1 F(ab) for 30 min before processing for immunofluoresence
microscopy. The localization of internalized E-cadherin (red) was com-
pared with that of endogenous Rab 7 (A, green), endogenous cathepsin
D (B, green), endogenous -COP (C, green), or transiently expressed
Cav3-YFP (D, green). Bars are 12 (A–C) and 4 m (D).
FIG. 5. Immunoelectron microscopic visualization of surface
E-cadherin. Cells were fixed with 0.5% glutaraldehyde, immunola-
beled for surface E-cadherin, and then processed for electron micros-
copy. Note that under these labeling conditions only surface E-cadherin
is accessible for immunolabeling. Gold particles are circled in panels
A–C. Labeling is evident within large invaginations of the cell surface
(panel A and higher magnification of boxed area in panel D) and is
particularly high in areas rich in surface projections (low magnification
overview in B). Low labeling is evident in clathrin-coated pits (arrow-
heads in C and D). Bars, 200 nm.
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pathways. Notably, endocytosis of the interleukin-2 receptor (a
transmembrane protein (41, 42) and glycosylphosphatidyl-
inositol-anchored proteins (30) also occurs independently of
transferrin and was not inhibited by EPS15 mutants, features
identical to those that we observed for E-cadherin.
Recent evidence that C-cadherin (14) and E-cadherin (23)
trafficking was perturbed by inhibition of dynamin suggested
the possibility that classical cadherins might be internalized
via a clathrin-dependent pathway. Indeed, we found that in the
current assay E-cadherin endocytosis was significantly inhib-
ited by dynaminS45N, although to a lesser extent than trans-
ferrin uptake. However, while dynamin was originally postu-
lated to specifically inhibit clathrin-mediated uptake, it is now
clear that this molecule can influence a range of other cellular
processes, including movement of the cell surface (43), the
clathrin-independent endocytosis of interleukin-2 receptors
(41), and internalization via caveolae (44). Taken together, our
data suggest strongly that in isolated MCF-7 cells E-cadherin
was endocytosed predominantly by a clathrin-independent
pathway.
Interestingly, our findings also indicate that after entry into
cells E-cadherin quite rapidly entered the early endosomal
system, being found in compartments that contained trans-
ferrin and EEA-1 and that were sensitive to Rab5. This, too, is
consistent with recent evidence that, in addition to classic
clathrin-mediated uptake (20, 32), some clathrin-independent
endocytosis pathways can also enter the early endosomal sys-
tem. For example, the folate receptor, a glycosylphosphatidyl-
inositol-anchored protein, is internalized by a clathrin-inde-
pendent mechanism, but is subsequently trafficked into a
transferrin-containing compartment before entering recycling
FIG. 6. E-cadherin internalization requires dynamin activity.
MCF-7 cells transiently expressing a dominant-negative dynamin 1
mutant (K45N) were allowed to internalize HECD-1 IgG (E-Cad; A and
B) or fluorescently labeled transferrin (Tfn; C and D) for 30 min before
processing for fluoresence microscopy. Transfected cells were identified
by co-staining for the HA-epitope tag (A and C; arrows). Expression of
the mutant transgene abolished the diffuse vesicular staining charac-
teristic of both internalized E-cadherin (B) and internalized transferrin
(D). E, to quantitate changes in internalization we counted the propor-
tion of cells with diffuse vesicular staining in untransfected cells and in
cells expressing the dynamin mutant (DynDN).
FIG. 7. E-cadherin internalization in isolated MCF-7 cells is
not affected by inhibition of EPS-15 activity. MCF-7 cells tran-
siently expressing a dominant-negative EPS-15E95/295 mutant
(EPS-15 DN; arrows) were allowed to internalize fluorescently labeled
transferrin (A and B) or HECD-1 F(ab) (C and D) for 30 min before
being processed for fluorescence microscopy. Expression of EPS-
15E95/295 inhibited the uptake of transferrin (A and B) but not uptake
of E-cadherin (C and D). Endocytosis was quantitated (E) by counting
the proportion of cells displaying a diffuse vesicular pattern of label in
untransfected cells and in cells expressing EPS-15E95/295.
E-cadherin Endocytosis 21055
 at UQ Library on September 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
endosomes (45). Recently internalized E-cadherin did not, how-
ever, appear to enter the late endosomal/lysosomal system.
Instead, our observation that internalized E-cadherin could
localize with Rab11 in a perinuclear site suggested that at least
a proportion of internalized E-cadherin could enter recycling
endosomes, a pathway that provides an attractive mechanism
for subsequently directing E-cadherin back to the cell surface.
What then might be the nature of this clathrin-independent
E-cadherin internalization pathway? An important clue comes
from the observation that E-cadherin internalization was strik-
ingly affected by constitutively active ARF6. Although
ARF6Q67L blocked the formation of cadherin-containing vesi-
cles, some degree of internalization appeared to transpire, be-
cause surface-labeled E-cadherin was commonly detected in
large peripheral compartments that resemble those previously
described to result from sustained ARF6 signaling (40). Simi-
larly, ARF6Q67L causes other proteins subject to clathrin-inde-
pendent endocytosis (MHC1, Tac) to accumulate in large pe-
ripheral structures, and consequently fail to fuse with early
endosomes (42). Furthermore, we found that the large cad-
herin-containing peripheral structures were devoid of either
internalized transferrin or EEA-1, suggesting that they might
correspond to the early vesicular compartment we identified.
This suggests that ARF6Q67L may affect a very early step after
cadherin entry, causing nascent vesicles to fuse and/or prevent
their progression to enter the early endosomal system. It was
also notable that in our cells E-cadherin labeled prominently in
surface invaginations and folds that resembled the ruffles and
macropinosomes that ARF6 is reported to regulate (40, 46).
Taken together, these data suggest that in isolated MCF-7 cells
E-cadherin was being internalized by ARF6-dependent mac-
ropinocytosis. Interestingly, dynamin also associates with mac-
ropinosomes (47), suggesting a possible mechanism for the role
of dynamin in E-cadherin internalization that we observed.
A role for ARF6 in cadherin trafficking was also recently
identified in Madin-Darby canine kidney cell monolayers,
where it was reported that ARF6Q67L potentiated E-cadherin
internalization while ARF6T27N inhibited internalization (23).
In our assays, however, ARF6 activity did not appear to im-
pinge on the actual step of internalization because the T27N
mutant had no apparent effect on endocytosis. It is possible
that this disparity in findings reflects a difference in the action
of ARF6 in isolated cells, as used in our studies, compared with
mature polarized monolayers. In our assay system surface E-
cadherin is predicted to be free and unoccupied by ligand,
whereas in mature epithelial monolayers the majority of cad-
herin would be expected to be engaged in homophilic binding.
Importantly, not only does contact appear to influence cadherin
internalization (13), but homophilic ligation also activates cad-
herin signaling (26, 48). Notably, ARF6 can affect both phos-
phoinositide signaling and the activity of the Rac GTPase (39,
49, 50), signals that E-cadherin activates to modulate adhesion
(26, 51). It is therefore possible that ARF6 influences not only
the process of cadherin endocytosis itself, but also the mecha-
nisms of cadherin engagement and/or signaling that support
surface adhesion. This would have implications for the adhe-
siveness, and hence availability for endocytosis, of E-cadherin
in monolayers but not in isolated cells. We are currently inves-
tigating the possibility that ARF6 may affect E-cadherin sig-
naling and adhesive recognition independently of its effects on
the cadherin internalization process.
In summary, our findings identify a novel clathrin-independ-
ent uptake pathway for E-cadherin in MCF-7 cells and suggest
that this may be the dominant endocytosis mechanism when
E-cadherin is free on the cell surface in isolated cells. Our
current findings do not exclude the possibility that clathrin-
mediated cadherin endocytosis also occurs in these cells. A
small proportion of E-cadherin was identified in clathrin-
coated pits and, moreover, if internalization through clathrin-
coated pits was very rapid, it might not have been detectable
with our techniques. Nor can we exclude the possibility that
differences in cell types studied influence the pathways of
endocytosis. The MCF-7 cell line used in our experiments,
although relatively well differentiated, derives from a human
tumor, in contrast to the Madin-Darby canine kidney cells used
in other studies (13, 17). Our current results, taken together
with our previous findings (13, 19) and those of other investi-
gators (15–18), thus suggest that there may be multiple path-
ways for cadherin internalization in different cellular contexts.
For example, fully confluent epithelial monolayers, where the
majority of E-cadherin is incorporated into adhesive contacts,
might be characterized by low levels of clathrin-mediated cad-
herin endocytosis. This would contrast with the more abundant
uptake of unligated cadherins seen in isolated cells that occurs
via the clathrin-independent, ARF-6-regulated pathway we
have now identified. Indeed, the endocytosis pathway iden-
tified in our experiments may be most directly relevant to
FIG. 8. ARF6 GTPase activity is necessary for traffic of E-
cadherin after initial endocytosis. MCF-7 cells transiently express-
ing wild-type ARF6 (A, Wt), dominant-negative ARF6T27N (B), or the
ARF6Q67L mutant lacking GTPase activity (C–F) were allowed to inter-
nalize HECD-1 F(ab) for 30 min before processing for fluorescence
microscopy. All cells shown expressed the appropriate transgenes as
identified by specific immunolabeling for the epitope tag. Wild-type
ARF6 (A) and ARF6T27N (B) did not affect E-cadherin internalization.
Expression of ARF6Q67L prevented internalization of E-cadherin into
diffuse small vesicles (C), which instead accumulated in large periph-
eral structures (D, detail of marked region in C). The large peripheral
structures (arrows) did not label for endogenous EEA-1 (green, E) or
internalized fluorescently labeled transferrin (green, F). Bar is 12 m.
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biological contexts where a significant proportion of cellular
E-cadherin is free, particularly dynamic morphogenetic pro-
cesses, including cell migration and wound healing (7, 12, 51).
These are situations where rapid remodeling of cadherin adhe-
sive contacts is likely to be physiologically active. More detailed
understanding of the mechanism(s) of E-cadherin endocytosis
will thus contribute to understanding how tissue context influ-
ences cadherin activity.
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